DOP2006000128A - Formulaciones farmaceúticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil) [4-(4-piridilmetil) ftalazin-1-ilo] micronizado y sus sales - Google Patents

Formulaciones farmaceúticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil) [4-(4-piridilmetil) ftalazin-1-ilo] micronizado y sus sales

Info

Publication number
DOP2006000128A
DOP2006000128A DO2006000128A DO2006000128A DOP2006000128A DO P2006000128 A DOP2006000128 A DO P2006000128A DO 2006000128 A DO2006000128 A DO 2006000128A DO 2006000128 A DO2006000128 A DO 2006000128A DO P2006000128 A DOP2006000128 A DO P2006000128A
Authority
DO
Dominican Republic
Prior art keywords
micronized
chlorophenyl
immediate release
salts
pharmaceutical formulations
Prior art date
Application number
DO2006000128A
Other languages
English (en)
Inventor
Thorsten Wagner
Kai Juergens
Thomas Backensfels
Adrian Funke
Kai Thode
Heiko Kranz
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DOP2006000128A publication Critical patent/DOP2006000128A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Formulaciones farmaceuticas sólidas de liberación inmediata y con una carga de droga elevada que comprenden (4clorofenil)[4-(4-piridilmetil)-ftalazin-l-ilo] micronizado, así como sus sales aceptables para use farmacéutico.
DO2006000128A 2005-06-07 2006-06-07 Formulaciones farmaceúticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil) [4-(4-piridilmetil) ftalazin-1-ilo] micronizado y sus sales DOP2006000128A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05090167A EP1731154A1 (en) 2005-06-07 2005-06-07 Immediate-release and high-drug-load pharmaceutical formulations of micronised (4-chlorophenyl)|4-(4-pyridylmethyl)pht halazin-1-yl| and salts thereof

Publications (1)

Publication Number Publication Date
DOP2006000128A true DOP2006000128A (es) 2006-12-15

Family

ID=34938468

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2006000128A DOP2006000128A (es) 2005-06-07 2006-06-07 Formulaciones farmaceúticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil) [4-(4-piridilmetil) ftalazin-1-ilo] micronizado y sus sales

Country Status (22)

Country Link
EP (2) EP1731154A1 (es)
JP (1) JP2008542421A (es)
KR (1) KR20080017443A (es)
CN (1) CN101242841A (es)
AR (1) AR054377A1 (es)
AU (1) AU2006256853A1 (es)
BR (1) BRPI0611818A2 (es)
CA (1) CA2610977A1 (es)
CR (1) CR9577A (es)
CU (1) CU20070272A7 (es)
DO (1) DOP2006000128A (es)
EC (1) ECSP078037A (es)
GT (1) GT200600243A (es)
IL (1) IL187906A0 (es)
MX (1) MX2007015495A (es)
NO (1) NO20080066L (es)
PE (1) PE20070012A1 (es)
RU (1) RU2007147953A (es)
TW (1) TW200716114A (es)
UY (1) UY29585A1 (es)
WO (1) WO2006131394A1 (es)
ZA (1) ZA200800113B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1958615A1 (en) * 2007-02-13 2008-08-20 Bayer Schering Pharma Aktiengesellschaft Solid pharmaceutical formulations of a homogeneous dispersion of active principles having pH-dependent solubility
EP1958616A1 (en) * 2007-02-13 2008-08-20 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical formulations of 1-[4-chloroanilino]-4-[4-pyridylmethyl] phthalazine or salts thereof
TW201618783A (zh) 2014-08-07 2016-06-01 艾森塔製藥公司 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4950519A1 (es) * 1997-02-13 2000-09-01 Novartis Ag Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion
CA2331620A1 (en) 1998-05-11 1999-11-18 The Endowment For Research In Human Biology, Inc. Use of neomycin for treating angiogenesis-related diseases

Also Published As

Publication number Publication date
CN101242841A (zh) 2008-08-13
CR9577A (es) 2008-03-06
BRPI0611818A2 (pt) 2010-09-28
GT200600243A (es) 2007-07-16
RU2007147953A (ru) 2009-07-20
TW200716114A (en) 2007-05-01
ZA200800113B (en) 2009-07-29
JP2008542421A (ja) 2008-11-27
KR20080017443A (ko) 2008-02-26
NO20080066L (no) 2008-03-06
ECSP078037A (es) 2008-01-23
MX2007015495A (es) 2008-02-22
CU20070272A7 (es) 2010-09-30
AR054377A1 (es) 2007-06-20
UY29585A1 (es) 2007-01-31
IL187906A0 (en) 2008-03-20
WO2006131394A1 (en) 2006-12-14
EP1731154A1 (en) 2006-12-13
CA2610977A1 (en) 2006-12-14
EP1888073A1 (en) 2008-02-20
PE20070012A1 (es) 2007-02-07
AU2006256853A1 (en) 2006-12-14

Similar Documents

Publication Publication Date Title
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
CR10573A (es) Derivados del pirazol como inhibidores del citocromo p450
ECSP088680A (es) Arildihidroisoquinolinonas sustituidas con azaciclilo, procedimiento para su preparación y su uso como medicamentos
CR20110110A (es) Composicion farmaceutica
CR20110611A (es) Sales de disacarina, ácido difumárico, ácido di-1-hidroxi-2-naftoico y ácido monobenzoico del 2-(4-((2-amino-4-metil-6-(pentilamino)pirimidin-5-il)metil)fenil) acetato de 4-(dimetilamino)butilo
UY33201A (es) Compuestos de pirazol como antagonistas de crth2.
UY31456A1 (es) Derivados de 2-pirazinona como inhibidores de la elastasa de los neutrofilos
UY31788A (es) Formulación farmacéutica sólida con liberación retardada
IL195269A0 (en) Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
CL2008000442A1 (es) Composicion farmaceutica que comprende a un quitosano, un ingrediente activo cosmetico o farmaceutico, y un solvente volatil; y su uso para tratar psoriasis, micosis entre otras enfermedades.
UY30163A1 (es) Nuevas ariltienopirimidinonas sustituidas con azaciclilo, procedimiento para su preparación y su uso como medicamentos
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
MXPA06011467A (es) Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid).
UY30165A1 (es) Nuevas arildihidroisoquinolinonas sustituidas con aminolcoholes, procedimiento para su preparación y su uso como medicamentos
AR082493A1 (es) Formulaciones a base de nalbufina, y sus utilizaciones
EA201001857A1 (ru) Фармацевтическая лекарственная форма для немедленного высвобождения производного индолинона
CR20120058A (es) Composiciones nuevas de 1 - [2 - (2,4-dimetil-fenilsulfanil)-fenil] piperazina
AR058047A1 (es) Administracion de inhibidores de dipeptidil peptidasa
UY31839A (es) Compuestos
ECSP13012832A (es) Compuestos de pirazol como antagonistas de crth2
DOP2006000128A (es) Formulaciones farmaceúticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil) [4-(4-piridilmetil) ftalazin-1-ilo] micronizado y sus sales
CR9563A (es) Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil)ftalazin-1-ilo] no micromizado, y sus sales
ES2561813T3 (es) Aplicación tópica de nimesulida y tiocolchicósido
CU20070271A7 (es) Formulaciones farmacéuticas de liberación inmediata y con una carga de droga elevada de (4-clorofenil) [4-4-piridilmetil) ftalazin-1-ilo] no micronizado y sus sales
UY29637A1 (es) Formulación de liberación prolongada de principios activos de medicamentos